Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has
Tonix Pharmaceuticals Announces IND Clearance For TNX-102 SL As A Potential Treatment For Long COVID Syndrome, Also Known As Post-Acute Sequelae Of COVID-19 (PASC)
Phase 2 Clinical Trial of TNX-102 SL for the Treatment of Long COVID Expected to Start Second Quarter 2022
Long COVID Afflicts More Than 30% of Patients Following Infection with SARS-CoV-2, the Virus that Causes
Tonix Pharmaceuticals Announces Extension Of Sponsored Research Agreement With Kansas State University To Develop Live-Virus Vaccine Against COVID-19
TNX-2300, a Live Virus Vaccine Based on a Bovine Parainfluenza Virus Vector, in Development to Protect Against COVID-19
Co-Expression of the CD40-Ligand Will be Tested to Direct Immune Response
CHATHAM, N.J.,
Shares Of Penny Stock Tonix Pharma Tick Higher On Volume Following Circulation Of Zack’s Small Cap Research Report Showing $1.50 Valuation Target On Stock
https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_03312022_TNXP_Bautz.pdf
Tonix Pharmaceuticals Reports Q4 EPS $(0.07) Up From $(0.10) YoY
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.07) per share. This is a 30 percent increase over losses of $(0.10) per share from the same period last year.
Tonix Pharma Collaborates With Massachusetts General Hospital For TNX-1900 In Binge Eating Disorder
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced an agreement with Massachusetts General Hospital to evaluate TNX-1900 (intranasal potentiated oxytocin) in a…
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Evaluate TNX-1900 for Treating Binge Eating Disorder
An Investigator Initiated Phase 2 Clinical Trial of TNX-1900 In Patients with Binge Eating Disorder Planned for Second Half 2022
Binge Eating Disorder is Estimated to Affect 2.8 Million American Adults1-3
Expands Uses
68 Biggest Movers From Friday
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.